Wells Fargo & Company Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $12.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target trimmed by Wells Fargo & Company from $15.00 to $12.00 in a research report released on Friday,Benzinga reports. The brokerage currently has an equal weight rating on the medical instruments supplier’s stock.

Several other equities research analysts have also recently weighed in on the company. UBS Group lowered their target price on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a report on Tuesday, October 28th. Wall Street Zen cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Barrington Research reaffirmed an “outperform” rating and issued a $18.00 price target on shares of DENTSPLY SIRONA in a research report on Wednesday, October 29th. Mizuho set a $13.00 target price on DENTSPLY SIRONA in a report on Friday. Finally, Evercore ISI dropped their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $16.42.

DENTSPLY SIRONA Trading Up 1.5%

NASDAQ XRAY opened at $11.18 on Friday. The stock has a market cap of $2.23 billion, a PE ratio of -2.36, a PEG ratio of 0.81 and a beta of 1.00. DENTSPLY SIRONA has a 12 month low of $10.69 and a 12 month high of $20.59. The company’s 50-day moving average price is $12.98 and its 200-day moving average price is $14.49. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The company had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Equities research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. raised its position in DENTSPLY SIRONA by 9.0% during the first quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock worth $7,391,000 after acquiring an additional 40,936 shares during the period. Brown Advisory Inc. acquired a new stake in DENTSPLY SIRONA in the 1st quarter worth about $679,000. Envestnet Portfolio Solutions Inc. increased its stake in DENTSPLY SIRONA by 36.9% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier’s stock worth $246,000 after buying an additional 4,165 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of DENTSPLY SIRONA during the first quarter valued at approximately $366,000. Finally, Krilogy Financial LLC purchased a new position in shares of DENTSPLY SIRONA in the second quarter valued at approximately $336,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.